Impact of left ventricular hypertrophy on myocardial injury in patients with ST-segment elevation myocardial infarction

Clinical Research in Cardiology

Volumn 107, Issue 11, 2018, Pages 1013-1020

  Stiermaier, Thomas ^a,b   Pöss, Janine ^a,b   Eitel, Charlotte ^a,b   de Waha, Suzanne ^a,b   Fuernau, Georg ^a,b   Desch, Steffen ^c   Thiele, Holger ^c   Eitel, Ingo ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cardiac magnetic resonance imaging; Left ventricular hypertrophy; Myocardial injury; Prognosis; ST segment elevation myocardial infarction

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL OUTCOME; CONTROLLED STUDY; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HUMAN; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL SALVAGE INDEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CARDIAC MUSCLE; CINE MAGNETIC RESONANCE IMAGING; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSIOLOGY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

AGED; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX; ST ELEVATION MYOCARDIAL INFARCTION; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 85046886848     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-018-1273-8     Document Type: Article

References (31)

1. Di Bella G, Siciliano V, Aquaro GD, Molinaro S, Lombardi M, Carerj S, Landi P, Rovai D, Pingitore A (2013) Scar extent, left ventricular end-diastolic volume, and wall motion abnormalities identify high-risk patients with previous myocardial infarction: a multiparametric approach for prognostic stratification. Eur Heart J 34(2):104–111. 10.1093/eurheartj/ehs037
2. Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van ‘t Hof A, Widimsky P, Zahger D (2012) ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569–2619. 10.1093/eurheartj/ehs215
3. Eitel I, de Waha S, Wohrle J, Fuernau G, Lurz P, Pauschinger M, Desch S, Schuler G, Thiele H (2014) Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64(12):1217–1226. 10.1016/j.jacc.2014.06.1194
4. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR (2008) The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (multi-ethnic study of atherosclerosis) study. J Am Coll Cardiol 52(25):2148–2155. 10.1016/j.jacc.2008.09.014
5. Tsang TS, Barnes ME, Gersh BJ, Takemoto Y, Rosales AG, Bailey KR, Seward JB (2003) Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 42(7):1199–1205 (pii:S0735109703009434)
6. Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD (2008) Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (valsartan in acute myocardial infarction) echocardiographic study. JACC Cardiovasc Imaging 1(5):582–591. 10.1016/j.jcmg.2008.05.012
7. Carluccio E, Tommasi S, Bentivoglio M, Buccolieri M, Filippucci L, Prosciutti L, Corea L (2000) Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction. Int J Cardiol 74(2–3):177–183 (pii:S0167527300002643)
8. Molgaard S, Faricelli B, Salomonsson M, Engstrom T, Treiman M (2016) Increased myocardial vulnerability to ischemia-reperfusion injury in the presence of left ventricular hypertrophy. J Hypertens 34(3):513–523. 10.1097/HJH.0000000000000826 (discussion 523)
9. Malek LA, Spiewak M, Klopotowski M, Petryka J, Mazurkiewicz L, Kruk M, Kepka C, Misko J, Ruzyllo W, Witkowski A (2012) Influence of left ventricular hypertrophy on infarct size and left ventricular ejection fraction in ST-elevation myocardial infarction. Eur J Radiol 81(3):e177–e181. 10.1016/j.ejrad.2011.01.088
10. Fernandez-Jimenez R, Silva J, Martinez-Martinez S, Lopez-Maderuelo MD, Nuno-Ayala M, Garcia-Ruiz JM, Garcia-Alvarez A, Fernandez-Friera L, Pizarro TG, Garcia-Prieto J, Sanz-Rosa D, Lopez-Martin G, Fernandez-Ortiz A, Macaya C, Fuster V, Redondo JM, Ibanez B (2015) Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study. J Am Heart Assoc 4(1):e001218. 10.1161/JAHA.114.001218
11. Thiele H, Wohrle J, Neuhaus P, Brosteanu O, Sick P, Prondzinsky R, Birkemeyer R, Wiemer M, Kerber S, Schuehlen H, Kleinertz K, Axthelm C, Zimmermann R, Rittger H, Braun-Dullaeus RC, Lauer B, Burckhardt W, Ferrari M, Bergmann MW, Hambrecht R, Schuler G (2010) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the abciximab intracoronary versus intravenously drug application in st-elevation myocardial infarction (AIDA STEMI) trial. Am Heart J 159(4):547–554. 10.1016/j.ahj.2009.12.038
12. Thiele H, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, Neuhaus P, Brosteanu O, Sick P, Wiemer M, Kerber S, Kleinertz K, Eitel I, Desch S, Schuler G (2012) Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet 379(9819):923–931. 10.1016/S0140-6736(11)61872-2
13. Desch S, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, Neuhaus P, Brosteanu O, Sick P, Pauschinger M, Kerber S, Kleinertz K, de Waha S, Eitel I, Schuler G, Thiele H (2013) Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial. J Am Coll Cardiol 62(13):1214–1215. 10.1016/j.jacc.2013.06.014
14. Eitel I, Wohrle J, Suenkel H, Meissner J, Kerber S, Lauer B, Pauschinger M, Birkemeyer R, Axthelm C, Zimmermann R, Neuhaus P, Brosteanu O, de Waha S, Desch S, Gutberlet M, Schuler G, Thiele H (2013) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol 61(13):1447–1454. 10.1016/j.jacc.2013.01.048
15. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G (2006) Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 47(8):1641–1645. 10.1016/j.jacc.2005.11.065
16. Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R, Plein S, Tee M, Eng J, Bluemke DA (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17:29. 10.1186/s12968-015-0111-7
17. Salton CJ, Chuang ML, O’Donnell CJ, Kupka MJ, Larson MG, Kissinger KV, Edelman RR, Levy D, Manning WJ (2002) Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol 39(6):1055–1060 (pii:S0735109702017126)
18. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH (2010) A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging 3(2):164–171. 10.1161/CIRCIMAGING.109.883652
19. Nepper-Christensen L, Lonborg J, Ahtarovski KA, Hofsten DE, Kyhl K, Ghotbi AA, Schoos MM, Goransson C, Bertelsen L, Kober L, Helqvist S, Pedersen F, Saunamaki K, Jorgensen E, Kelbaek H, Holmvang L, Vejlstrup N, Engstrom T (2017) Left ventricular hypertrophy is associated with increased infarct size and decreased myocardial salvage in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Am Heart Assoc. 10.1161/JAHA.116.004823
20. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP (1987) Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59(9):956–960 (pii:0002-9149(87)91133-7)
21. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R (1992) Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86(1):38–46
22. Eitel I, Poss J, Jobs A, Eitel C, de Waha S, Barkhausen J, Desch S, Thiele H (2015) Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction. J Cardiovasc Magn Reson 17:62. 10.1186/s12968-015-0161-x
23. Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS, Wong ND, Smith VE, Gottdiener J (2001) M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the cardiovascular health study). Am J Cardiol 87(9):1051–1057 (pii:S0002-9149(01)01460-6)
24. Behar S, Reicher-Reiss H, Abinader E, Agmon J, Barzilai J, Friedman Y, Kaplinsky E, Kauli N, Kishon Y, Palant A et al (1992) Long-term prognosis after acute myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram. SPRINT study group. Am J Cardiol 69(12):985–990
25. Georgescu A, Fu Y, Yau C, Hassan Q, Luchansky J, Armstrong PW, Wagner G, Van de Werf F, Goodman SG, Assessment of the Safety and Efficacy of a New Thrombolytic Regimen Trial (ASSENT-III) Investigators (2005) Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction. Am J Cardiol 96(8):1050–1052. 10.1016/j.amjcard.2005.06.029
26. Westerhout CM, Lauer MS, James S, Fu Y, Wallentin L, Armstrong PW, Investigators GIA (2007) Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women. Eur Heart J 28(17):2064–2069. 10.1093/eurheartj/ehm223
27. Missouris CG, Forbat SM, Singer DR, Markandu ND, Underwood R, MacGregor GA (1996) Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens 14(8):1005–1010
28. Turschner O, D’Hooge J, Dommke C, Claus P, Verbeken E, De Scheerder I, Bijnens B, Sutherland GR (2004) The sequential changes in myocardial thickness and thickening which occur during acute transmural infarction, infarct reperfusion and the resultant expression of reperfusion injury. Eur Heart J 25(9):794–803. 10.1016/j.ehj.2004.01.006
29. Younger JF, Plein S, Barth J, Ridgway JP, Ball SG, Greenwood JP (2007) Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart 93(12):1547–1551. 10.1136/hrt.2006.109249
30. Kim HW, Van Assche L, Jennings RB, Wince WB, Jensen CJ, Rehwald WG, Wendell DC, Bhatti L, Spatz DM, Parker MA, Jenista ER, Klem I, Crowley AL, Chen EL, Judd RM, Kim RJ (2015) Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res 117(3):254–265. 10.1161/CIRCRESAHA.117.305771
31. Fernandez-Jimenez R, Sanchez-Gonzalez J, Aguero J, Garcia-Prieto J, Lopez-Martin GJ, Garcia-Ruiz JM, Molina-Iracheta A, Rossello X, Fernandez-Friera L, Pizarro G, Garcia-Alvarez A, Dall’Armellina E, Macaya C, Choudhury RP, Fuster V, Ibanez B (2015) Myocardial edema after ischemia/reperfusion is not stable and follows a bimodal pattern: imaging and histological tissue characterization. J Am Coll Cardiol 65(4):315–323. 10.1016/j.jacc.2014.11.004